BE616646A
(en)
|
|
|
|
|
DE1124485B
(en)
|
1960-02-12 |
1962-03-01 |
Hoechst Ag |
Process for the preparation of analeptically active phenylcycloalkylmethylamines
|
US3496181A
(en)
*
|
1966-10-24 |
1970-02-17 |
Upjohn Co |
2 - aminocycloalkyl hydroquinones,esters,ethers and n-oxides thereof,and a process for preparing the same
|
GB1207731A
(en)
*
|
1968-05-14 |
1970-10-07 |
Reckitt & Sons Ltd |
Derivatives of pyrrolidine
|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
US3974157A
(en)
|
1974-03-04 |
1976-08-10 |
Pennwalt Corporation |
1-(Amino-alkyl)-2-aryl-cyclohexane alcohols and esters
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
US4287212A
(en)
*
|
1976-04-30 |
1981-09-01 |
American Hoechst Corporation |
2-Aryl-1,2-dialkylcycloalkylamines
|
JPS6033106B2
(en)
|
1977-10-07 |
1985-08-01 |
住友化学工業株式会社 |
Carboxylic acid esters, their production methods, and insecticides and acaricides containing them as active ingredients
|
ZA817261B
(en)
|
1980-10-23 |
1982-09-29 |
Schering Corp |
Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
|
ZA829562B
(en)
*
|
1982-02-09 |
1983-10-26 |
Upjohn Co |
2-(phenylmethylene)cycloalkylamines and-azetidines
|
US4540690A
(en)
*
|
1982-02-09 |
1985-09-10 |
The Upjohn Company |
2-(Phenylmethylene)cycloalkylamines and -azetidines
|
JPS58177915A
(en)
|
1982-04-12 |
1983-10-18 |
Green Cross Corp:The |
Antithrombotic agent
|
EP0152032B1
(en)
|
1984-02-03 |
1988-10-26 |
Olympus Optical Co., Ltd. |
Calculus crushing apparatus
|
JPS60172970A
(en)
*
|
1984-02-15 |
1985-09-06 |
Shionogi & Co Ltd |
Cis-azolylcycloalkanol derivative, its preparation and fungicide for agricultural use
|
EP0190224A1
(en)
|
1984-07-30 |
1986-08-13 |
Schering Corporation |
PROCESS FOR THE PREPARATION OF CIS, ENDOOCTAHYDROCYCLOPENTA [b] PYRROLE-2-CARBOXYLATE
|
DE3431541A1
(en)
|
1984-08-28 |
1986-03-06 |
Hoechst Ag, 6230 Frankfurt |
CIS, ENDO-2-AZABICYCLOALKAN-3-CARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AND INTERMEDIATE PRODUCTS IN THEIR PRODUCTION
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
US4738709A
(en)
|
1985-01-10 |
1988-04-19 |
Ppg Industries, Inc. |
Herbicidally active substituted benzisoxazoles
|
US4751231A
(en)
|
1987-09-16 |
1988-06-14 |
Merck & Co., Inc. |
Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
|
JPH01172388A
(en)
|
1987-12-25 |
1989-07-07 |
Sumitomo Chem Co Ltd |
Thieno(3,2-b)pyrrolo(2,3-d)pyrroles and production thereof
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
US4981870A
(en)
|
1989-03-07 |
1991-01-01 |
Pfizer Inc. |
Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
|
IT1229203B
(en)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
USE OF 5 METHYLTHETRAHYDROPHOLIC ACID, 5 FORMYLTHETRAHYDROPHOLIC ACID AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE ACTIVE IN THE THERAPY OF MENTAL AND ORGANIC DISORDERS.
|
PT93943A
(en)
|
1989-05-05 |
1991-02-08 |
Searle & Co |
PROCESS FOR THE PREPARATION OF COMPOUNDS CONTAINING INDOLE-2-CARBOXYLATE COMPOUNDS FOR TREATMENT OF CNS DISTURBACTIONS
|
ATE172712T1
(en)
|
1989-05-31 |
1998-11-15 |
Upjohn Co |
CNS-ACTIVE 8-HETEROCYCLYL-2-AMINOTETRALIN DERIVATIVES
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
ATE126511T1
(en)
|
1990-02-02 |
1995-09-15 |
Schering Corp |
4,5-CYCLOALKANO-3-BENZAZEPINE-7-OL DERIVATIVES AND THEIR USE.
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
JPH0477476A
(en)
|
1990-07-19 |
1992-03-11 |
Sankyo Co Ltd |
Antiulcer agent
|
US5086054A
(en)
|
1990-07-31 |
1992-02-04 |
Sri International |
Novel arylcycloalkanepolyalkylamines
|
JP3007138B2
(en)
|
1990-11-27 |
2000-02-07 |
ファイザー製薬株式会社 |
Novel hydroxamic acid and N-hydroxyurea derivatives and compositions thereof
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
GB9208492D0
(en)
|
1992-04-16 |
1992-06-03 |
Glaxo Spa |
Heterocyclic compounds
|
EP0665226A1
(en)
|
1992-10-28 |
1995-08-02 |
Toyama Chemical Co., Ltd. |
Novel 1,2-benzisoxazole derivative or salt thereof, and brain protective agent comprising the same
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
GB9304500D0
(en)
|
1993-03-05 |
1993-04-21 |
Glaxo Spa |
Heterocyclic compounds
|
ES2081747B1
(en)
|
1993-09-07 |
1997-01-16 |
Esteve Labor Dr |
AMIDES DERIVED FROM TIENOPIRROLES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINES.
|
GB9321221D0
(en)
|
1993-10-14 |
1993-12-01 |
Glaxo Spa |
Heterocyclic compounds
|
GB9326284D0
(en)
|
1993-12-23 |
1994-02-23 |
Erba Carlo Spa |
Pyrrolydenemethyl-derivatives and process for their preparation
|
IT1270594B
(en)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION OF LIQUID SUSPENSION MOGUISTEIN
|
CN1047384C
(en)
|
1994-07-28 |
1999-12-15 |
北京大学 |
Synthetic process of Ramipril
|
MX9701630A
(en)
|
1994-08-30 |
1997-06-28 |
Sankyo Co |
Isoxazoles.
|
US5484763A
(en)
|
1995-02-10 |
1996-01-16 |
American Cyanamid Company |
Substituted benzisoxazole and benzisothiazole herbicidal agents
|
US5620997A
(en)
|
1995-05-31 |
1997-04-15 |
Warner-Lambert Company |
Isothiazolones
|
US5859042A
(en)
|
1995-09-27 |
1999-01-12 |
Ono Pharmaceutical Co., Ltd. |
Five membered heterocyclic compounds
|
CZ126598A3
(en)
|
1995-10-26 |
1998-09-16 |
Mitsubishi-Tokyo Pharmaceuticals, Inc. |
Phenylethanolamine compounds, process of their preparation and pharmaceutical compositions containing thereof
|
CZ289340B6
(en)
*
|
1996-01-31 |
2002-01-16 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Phenanthridine derivatives and pharmaceutical preparations in which they are comprised
|
DE19711785A1
(en)
|
1997-03-21 |
1998-09-24 |
Merck Patent Gmbh |
Endothelin receptor antagonists
|
US6503582B1
(en)
|
1997-08-19 |
2003-01-07 |
Mattel, Inc. |
Fluid-swellable composition, device and method for using the same
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
WO1999018065A1
(en)
|
1997-10-03 |
1999-04-15 |
Chirotech Technology Limited |
Chiral amines
|
GB9803226D0
(en)
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
GB9803228D0
(en)
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
JP2002507598A
(en)
|
1998-03-26 |
2002-03-12 |
スージェン・インコーポレーテッド |
A family of heterocyclic compounds for regulating tyrosine protein kinase
|
US6476078B2
(en)
|
1999-08-11 |
2002-11-05 |
Sepracor, Inc. |
Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
|
US6632836B1
(en)
|
1998-10-30 |
2003-10-14 |
Merck & Co., Inc. |
Carbocyclic potassium channel inhibitors
|
CN1329590A
(en)
*
|
1998-12-02 |
2002-01-02 |
达尔文发现有限公司 |
Therapeutic product and its use
|
US6828460B2
(en)
*
|
1999-03-22 |
2004-12-07 |
Pfizer Inc. |
Resorcinol derivatives
|
DE19915601A1
(en)
*
|
1999-04-07 |
2000-10-19 |
Gruenenthal Gmbh |
3-Amino-3-arylpropan-1-ol derivatives, their preparation and use
|
FR2795733B1
(en)
|
1999-06-30 |
2001-09-07 |
Aventis Pharma Sa |
STREPTOGRAMIN DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM
|
EP1391460A1
(en)
|
1999-09-30 |
2004-02-25 |
Pfizer Products Inc. |
Tricyclic pyrrolyl amides as glycogen phosphorylase inhibitors
|
DE60007592T2
(en)
|
1999-09-30 |
2004-09-16 |
Pfizer Products Inc., Groton |
Bicyclic pyrrolylamides as glycogen phosphorylase inhibitors
|
IL148820A0
(en)
|
1999-10-08 |
2002-09-12 |
Smithkline Beecham Corp |
Fab i inhibitors
|
ATE402140T1
(en)
*
|
1999-12-08 |
2008-08-15 |
Lilly Co Eli |
CYCLOPENTYL SULFONAMIDE DERIVATIVES
|
DE19960917A1
(en)
|
1999-12-17 |
2001-06-21 |
Bayer Ag |
New 3-oxo-2,1-benzisoxazol-1 (3H) -carboxamides for the treatment of CNS diseases
|
DE10000312A1
(en)
|
2000-01-05 |
2001-07-12 |
Gruenenthal Gmbh |
Substituted aminomethyl phenyl cyclohexane derivatives
|
US6632417B2
(en)
|
2000-03-07 |
2003-10-14 |
Chevron U.S.A. Inc. |
Process for preparing zeolites
|
JP2001247462A
(en)
|
2000-03-07 |
2001-09-11 |
Otsuka Pharmaceut Co Ltd |
Urease inhibitor
|
EP1136071A3
(en)
|
2000-03-22 |
2003-03-26 |
Pfizer Products Inc. |
Use of glycogen phosphorylase inhibitors
|
WO2001079208A1
(en)
|
2000-04-19 |
2001-10-25 |
Kaneka Corporation |
Novel azetidine derivative and process for preparation thereof
|
GB0012214D0
(en)
|
2000-05-19 |
2000-07-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
AU2001280461A1
(en)
|
2000-08-04 |
2002-02-18 |
Eli Lilly And Company |
Substituted pyrrole compounds and their use as spla2 inhibitors
|
GB0021831D0
(en)
|
2000-09-06 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
DE10049481A1
(en)
|
2000-09-29 |
2002-05-02 |
Gruenenthal Gmbh |
Substituted C-cyclohexylmethylamine derivatives
|
DE10049483A1
(en)
*
|
2000-09-29 |
2002-05-02 |
Gruenenthal Gmbh |
Substituted 1-aminobutan-3-ol derivatives
|
AU2000277557A1
(en)
|
2000-10-06 |
2002-04-22 |
Smith Kline Beecham Corporation |
Methods of agonizing and antagonizing fabk
|
WO2002032858A1
(en)
*
|
2000-10-13 |
2002-04-25 |
Eli Lilly And Company |
Cycloalkylfluorosulfonamide derivatives
|
SE0003810D0
(en)
|
2000-10-20 |
2000-10-20 |
Pharmacia Ab |
Novel compounds their use and preparations
|
TWI283575B
(en)
|
2000-10-31 |
2007-07-11 |
Eisai Co Ltd |
Medicinal compositions for concomitant use as anticancer agent
|
DE10063992A1
(en)
|
2000-12-21 |
2002-07-04 |
Max Planck Gesellschaft |
Tryptophan analogues in proteins, peptides and peptide lead structures
|
US6372919B1
(en)
|
2001-01-11 |
2002-04-16 |
Dov Pharmaceutical, Inc. |
(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
|
US20020123490A1
(en)
|
2001-03-01 |
2002-09-05 |
Pfizer Inc. |
Combination treatment for anxiety, depression, obsessive compulsive disorder and psychosis
|
US7365205B2
(en)
|
2001-06-20 |
2008-04-29 |
Daiichi Sankyo Company, Limited |
Diamine derivatives
|
GB0115602D0
(en)
|
2001-06-26 |
2001-08-15 |
Syngenta Participations Ag |
Organic compounds
|
DE10132747A1
(en)
*
|
2001-07-05 |
2003-01-23 |
Gruenenthal Gmbh |
Substituted 1-aryl-but-3-enylamine and 1-aryl-but-2-enylamine compounds
|
US6603000B2
(en)
|
2001-07-11 |
2003-08-05 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Synthesis for heteroarylamine compounds
|
MXPA04001272A
(en)
|
2001-08-09 |
2004-05-27 |
Daiichi Seiyaku Co |
Diamine derivatives.
|
US7045543B2
(en)
|
2001-11-05 |
2006-05-16 |
Enzrel Inc. |
Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
|
WO2003039540A2
(en)
|
2001-11-09 |
2003-05-15 |
Sepracor Inc. |
D-amino acid oxidase inhibitors for learning and memory
|
US6780891B2
(en)
*
|
2001-11-30 |
2004-08-24 |
Sepracor Inc. |
Tramadol analogs and uses thereof
|
DE10164581A1
(en)
*
|
2001-12-14 |
2003-06-26 |
Gruenenthal Gmbh |
Medicaments that inhibit noradrenaline reuptake, useful e.g. for treating emesis, diarrhea, inflammation, depression or especially pain, comprise new or known cyclic aminomethyl-substituted alcohols
|
DE10161809A1
(en)
*
|
2001-12-14 |
2003-06-26 |
Gruenenthal Gmbh |
Pharmaceutical compositions, useful e.g. for the treatment of neurodegenerative diseases, psychiatric or neuropathological diseases or especially pain and epilepsy, comprise N,N'-disubstituted piperazine derivatives
|
TW200307539A
(en)
|
2002-02-01 |
2003-12-16 |
Bristol Myers Squibb Co |
Cycloalkyl inhibitors of potassium channel function
|
DE60327691D1
(en)
*
|
2002-02-11 |
2009-07-02 |
Rhodia Chimie Sa |
DETERGENT WITH BLOCK COPOLYMER
|
GB0205170D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
GB0205165D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
AU2003227360A1
(en)
|
2002-04-25 |
2003-11-10 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel amide derivatives or salts thereof
|
AU2003236247A1
(en)
|
2002-05-03 |
2003-11-17 |
Warner-Lambert Company Llc |
Bombesin antagonists
|
FR2841487B1
(en)
|
2002-06-26 |
2004-08-20 |
Solystic |
METHOD FOR DETECTING SINGLE PLIERS AND MULTIPLE PLUG PLUGS IN A POSTAL SORTING FACILITY
|
DE10233048A1
(en)
|
2002-07-19 |
2004-01-29 |
Grünenthal GmbH |
Use of 1-phenyl-3dimethylamino-propane compounds for the treatment of depressive symptoms
|
US20050182131A1
(en)
*
|
2002-07-19 |
2005-08-18 |
Gruenenthal Gmbh |
1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
|
AU2003252299A1
(en)
|
2002-07-31 |
2004-02-16 |
Eisai Co., Ltd. |
Novel physiologically active substance
|
US7537891B2
(en)
|
2002-08-27 |
2009-05-26 |
Bristol-Myers Squibb Company |
Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
|
DE60305052T2
(en)
|
2002-09-06 |
2006-12-21 |
Janssen Pharmaceutica N.V. |
THIENOPYRROLYL AND FURANOPYRROLYL COMPOUNDS AND THEIR USE AS HISTAMINE H4 RECEPTOR LIGANDS
|
MXPA05002700A
(en)
|
2002-09-16 |
2005-09-08 |
Sepracor Inc |
Treatment of cns disorders with trans.
|
US20040087661A1
(en)
|
2002-09-16 |
2004-05-06 |
Sepracor, Inc. |
Treatment of CNS disorders with trans 4-3(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine
|
TW200418838A
(en)
*
|
2002-09-18 |
2004-10-01 |
Bristol Myers Squibb Co |
Compounds for the treatment of premature ejaculation
|
GB0222912D0
(en)
|
2002-10-03 |
2002-11-13 |
Astrazeneca Ab |
Novel process and intermediates
|
JP2006504795A
(en)
|
2002-10-03 |
2006-02-09 |
サイプレス バイオサイエンス, インコーポレイテッド |
Step-by-step escalation of antidepressant dosage to treat neurological disorders and daily divided doses
|
GB0222909D0
(en)
|
2002-10-03 |
2002-11-13 |
Astrazeneca Ab |
Novel process and intermediates
|
US20040097554A1
(en)
|
2002-10-30 |
2004-05-20 |
Pfizer Inc |
Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
|
WO2004041780A2
(en)
|
2002-11-07 |
2004-05-21 |
Pfizer Products Inc. |
N-(indole-2-carbonyl) amides as anti-diabetic agents
|
US7345180B2
(en)
|
2003-01-31 |
2008-03-18 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
Compound inhibiting dipeptidyl peptidase IV
|
ATE482747T1
(en)
|
2003-04-11 |
2010-10-15 |
High Point Pharmaceuticals Llc |
NEW AMIDE DERIVATIVES AND THEIR PHARMACEUTICAL USES
|
CA2521962A1
(en)
|
2003-04-30 |
2004-11-11 |
Pfizer Products Inc. |
Anti-diabetic agents
|
WO2004113345A1
(en)
|
2003-06-20 |
2004-12-29 |
Japan Tobacco Inc. |
Fused pyrrole compound and medicinal use thereof
|
ATE360638T1
(en)
|
2003-06-30 |
2007-05-15 |
Servier Lab |
METHOD FOR THE SYNTHESIS OF PERINDOPRIL AND ITS PHARMACEUTICALLY SUITABLE SALTS
|
JP4745226B2
(en)
|
2003-07-07 |
2011-08-10 |
チバ ホールディング インコーポレーテッド |
Production of flopirole
|
SG145693A1
(en)
|
2003-07-29 |
2008-09-29 |
Signature R & D Holdings Llc |
Amino acid prodrugs
|
GB0318463D0
(en)
|
2003-08-07 |
2003-09-10 |
Astrazeneca Ab |
Chemical compounds
|
GB0319759D0
(en)
|
2003-08-22 |
2003-09-24 |
Astrazeneca Ab |
Chemical compounds
|
WO2005020986A1
(en)
|
2003-08-29 |
2005-03-10 |
Astrazeneca Ab |
Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
|
GB0320422D0
(en)
|
2003-08-30 |
2003-10-01 |
Astrazeneca Ab |
Chemical compounds
|
KR100798161B1
(en)
|
2003-10-23 |
2008-01-28 |
에프. 호프만-라 로슈 아게 |
Triaza-spiropiperidine derivatives for use as glyt-1 inhibitors in the treatment of neurological and neuropsychiatric disorders
|
US7396940B2
(en)
|
2003-10-23 |
2008-07-08 |
Hoffmann-La Roche Inc. |
Combinatorial library of 3-aryl-1H-indole-2-carboxylic acid
|
SI1420028T1
(en)
|
2003-11-19 |
2007-06-30 |
Servier Lab |
Method for synthesis of perindopril and its pharmaceutically acceptable salts
|
BRPI0417910A
(en)
|
2003-12-29 |
2007-04-10 |
Sepracor Inc |
compound or a pharmaceutically acceptable salt or salvate thereof, and use of a compound
|
PL380887A1
(en)
|
2003-12-29 |
2007-04-02 |
Sepracor Inc. |
Pyrrole and pyrazole DAAO inhibitors
|
US20070197610A1
(en)
|
2004-03-16 |
2007-08-23 |
Janssen Pharmaceutica N.V. |
Benzisoxazoles
|
GEP20094826B
(en)
|
2004-05-07 |
2009-11-10 |
Warner Lambert Co |
3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
|
MXPA06013270A
(en)
*
|
2004-05-14 |
2007-04-23 |
Johnson & Johnson |
Carboxamido opioid compounds.
|
CA2567851A1
(en)
*
|
2004-05-21 |
2006-01-05 |
Merck & Co., Inc. |
Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
|
TWI335816B
(en)
|
2004-05-26 |
2011-01-11 |
Eisai R&D Man Co Ltd |
Cinnamide compound
|
WO2005123677A1
(en)
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
|
CN102827082B
(en)
|
2004-07-01 |
2015-01-07 |
第一三共株式会社 |
Thienopyrazole derivative having PDE7 inhibitory activity
|
US7276631B2
(en)
*
|
2004-07-20 |
2007-10-02 |
Bristol-Myers Squibb Company |
Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists
|
JO2629B1
(en)
|
2004-08-19 |
2012-06-24 |
افينتيس فارما سوتيكالز انك |
Substituted Thenopyrrole carboxylic acid amids, Pyrrolothiazole carboxylic acid amids,and related analogs as inhibitors of casein kinase I epsilon
|
US7411093B2
(en)
*
|
2004-12-20 |
2008-08-12 |
Hoffman-La Roche Inc. |
Aminocycloalkanes as DPP-IV inhibitors
|
EP1844051A1
(en)
|
2005-01-19 |
2007-10-17 |
Biolipox AB |
Thienopyrroles useful in the treatment of inflammation
|
CN100391945C
(en)
|
2005-05-31 |
2008-06-04 |
浙江大学 |
S-(-)-indolyl-2-carboxylic acid synthesizing method
|
CA2624795A1
(en)
|
2005-10-06 |
2007-04-12 |
Merck Sharp & Dohme Limited |
Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as d-amino acid oxidase inhibitors
|
UA95788C2
(en)
|
2005-12-15 |
2011-09-12 |
Ф. Хоффманн-Ля Рош Аг |
Fused pyrrole derivatives
|
JP5438975B2
(en)
|
2006-01-06 |
2014-03-12 |
サノビオン ファーマシューティカルズ インク |
Tetralone monoamine reuptake inhibitor
|
ES2594156T3
(en)
|
2006-01-06 |
2016-12-16 |
Sunovion Pharmaceuticals Inc. |
Cycloalkylamines as monoamine reuptake inhibitors
|
WO2007115185A2
(en)
|
2006-03-31 |
2007-10-11 |
Sepracor Inc. |
Preparation of chiral amides and amines
|
US7884124B2
(en)
|
2006-06-30 |
2011-02-08 |
Sepracor Inc. |
Fluoro-substituted inhibitors of D-amino acid oxidase
|
WO2008005456A2
(en)
|
2006-06-30 |
2008-01-10 |
Sepracor Inc. |
Fused heterocyclic inhibitors of d-amino acid oxidase
|
US7579370B2
(en)
|
2006-06-30 |
2009-08-25 |
Sepracor Inc. |
Fused heterocycles
|
US20080058395A1
(en)
|
2006-06-30 |
2008-03-06 |
Sepracor Inc. |
Fused heterocyclic inhibitors of D-amino acid oxidase
|
CN1962656A
(en)
|
2006-11-29 |
2007-05-16 |
沈阳药科大学 |
Indomethacin 5-fluorouracil methyl ester pharmaceutical compound and its formulation and preparation method
|
WO2008079382A1
(en)
*
|
2006-12-21 |
2008-07-03 |
Abbott Laboratories |
Sphingosine-1 -phosphate receptor agonist and antagonist compounds
|
WO2008089453A2
(en)
|
2007-01-18 |
2008-07-24 |
Sepracor Inc. |
Inhibitors of d-amino acid oxidase
|
US7902252B2
(en)
|
2007-01-18 |
2011-03-08 |
Sepracor, Inc. |
Inhibitors of D-amino acid oxidase
|
NZ580429A
(en)
*
|
2007-05-31 |
2012-04-27 |
Sepracor Inc |
Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
|
WO2010017418A1
(en)
|
2008-08-07 |
2010-02-11 |
Sepracor Inc. |
Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
|